Download

Download Full Text (339 KB)

Contents

  • New Targeted Therapy Offers Hope to Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, Related Diseases: The treatment of common hematological malignancies is based on reams of study data and years of physician experience with the diseases. But such information is often limited for rare, little-researched blood cancers like blastic plasmacytoid dendritic cell neoplasm (BPDCN). This situation may soon change, thanks to the discovery of a new molecular target, which has led to a spate of innovative treatment approaches and the first dedicated clinical trials for this uncommon malignancy.
  • Laparoscopic Free Omental Lymphatic Flap Transfers Offer a Powerful Alternative for Lymphedema Treatment: Armed with new laparoscopic and microsurgical techniques, surgeons are revisiting the use of omental flaps to safely and effectively treat lymphedema in breast cancer patients.
  • Naproxen Shows Potential for Chemoprevention in Patients with Lynch Syndrome: People with Lynch syndrome face a high risk of colorectal cancer. But researchers think that reducing this risk may be as easy as taking a daily over-the-counter pill.
  • HOUSE CALL: Preparing for a Hospital Stay- What to bring-and what to leave at home-to make your stay more pleasant
  • INBRIEF: Beta-Blockers May Prolong Ovarian Cancer Patients' Survival

Publication Date

10-1-2015

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Pemmaraju, Naveen; Konopleva, Marina; Frankel, Arthur E.; Nguyen, Alexander; Wong, Franklin C. L.; Suami, Hiroo; Sanchez, Eduardo Vilar; Sood, Anil, M.D.; Hematologic Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Receptors, Interleukin-3; Recombinant Fusion Proteins; Leukemia, Myeloid, Acute; Myeloproliferative Disorders; Lymphedema; Lymph Nodes; Omentum; Colorectal Neoplasms, Hereditary Nonpolyposis; Genetic Counseling; Length of Stay; Adrenergic beta-Antagonists; Ovarian Neoplasms; Naproxen.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 60, Number 10, October 2015

Share

COinS